Putnam Biorevolution ETFSYNBETF
13F holders, Q3 2024 (September 30)4holders +1
1new positions
0sold out
$32.82avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Putnam Biorevolution ETF (SYNB) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Franklin Resources Inc. ($4.1M), Royal Bank of Canada ($162K) and UBS Group AG ($364).
- Company
- Putnam Biorevolution ETF
- CUSIP
- 746729805
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $66 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 3,921 shares bought and 1 shares sold, net +3,920 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Franklin Resources Inc. | 0.00% | No change | 125,000 | $4.1M |
| Royal Bank of Canada | 0.00% | Add +396.3% | 4,908 | $162K |
| UBS Group AG | 0.00% | Reduce -8.3% | 11 | $364 |
| Osaic Holdings, Inc. | 0.00% | New | 2 | $66 |
"% of holder's portfolio" is SYNB's weight in each manager's 13F, not the share of Putnam Biorevolution ETF the manager owns.